The c-Met receptor tyrosine kinase inhibitor MP470 radiosensitizes glioblastoma cells James W Welsh,Daruka Mahadevan,et al. Radiation Oncology 2009;4:69
MP470, a novel receptor tyrosine kinase inhibitor, in combination with Erlotinib inhibits the HER family/PI3K/Akt pathway and tumor growth in prostate cancer Wenqing Qi,Larry S Cooke,et al. BMC Cancer 2009; 9:142
The pharmacological and toxicological properties of this product have not been fully investigated. Exercise caution in use and handling. This product must not be used in humans.